Celgene (CELG) Invests Potentially Billions in OncoMed's (OMED) Technology that Targets Cancer Stem Cells
Tweet Send to a Friend
In a groundbreaking move, biotech giant Celgene (NASDAQ: CELG) made a commitment to invest up to $1.6 billion dollars or ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
